Podcasts about CRX

Today on the radio show. 1 - Smoko chat. Jay’s mates CRX. 5 - Overcapitalised on what? 10 - Origin gee up. 15 - Adult problems you weren’t aware of. 19 - Being an adult means. 22 - Hygiene with Stone Cold. 27 - Just got on with it ay. 32 - Daily Dump. https://bit.ly/3S5KseE 35 - Big Ben XXL. 39 - Some car yarn from Hamilton. 42 - Stitching up ants. 46 - Must watch. Race for the Crown. https://bit.ly/43pLTdg 50 - Late mail. 53 - Last drinks. Get in touch with us: https://linktr.ee/therockdrive

Este año estoy haciendo muchos planes para conocer sitios nuevos y seguro que vosotros también, para todos nosotros que nos encanta ir de aquí pa allá, una escapada, una quedada con amigos, pues ya sabes que BP Ultimate puede llevarte hasta 840km más lejos al año. Me he propuesto viajar más, recorrer carreteras poco conocidas, descubrir pueblos con encanto, paisajes, personajes, todo esto se ha convertido en mi mayor afición y os digo una cosa BP es mi mejor aliado. Porque repostando BP Ultimate cuido mi motor y puedo llegar hasta 840 km más lejos cada año comparado con combustibles básicos y basado en un uso continuado de 13.000 km. Lógicamente los beneficios pueden varias en función del vehículo, estilo de conducción, condiciones del asfalto y otros factores. Tenéis toda la información en https://www.bepear.es Aunque me quiero centrar en los coches, la historia de Honda no se pude entender sin hablar de dos motos que son clave en su historia. La primera, la Honda Super Cub nacida en 1958 y que posee el título de moto más vendida de la historia… ¡casi 100 millones de unidades! La segunda, la Honda 750 Four aparecida el 1969 y considerada la primera Super Bike de la historia una moto de alta cilindrada que ofrecía calidad, prestaciones y facilidad de uso por poco dinero. #coches #automoviles #honda #hondacivic Con esa moto se inició una campaña de marketing que se ha convertido en un referente: “Conoces a la gente más agradable en una Honda”. Honda había conseguido, por primera vez, que la motocicleta se viera como un medio de transporte cotidiano, práctico, limpio, cómodo y socialmente respetado, no como el vehículo de los malos. Hemos hablado de motos clave… ahora hablemos de coches clave en la historia de la marca. Tras la camioneta T360, el S500 de 1963 y 1964 y su sucesor el S600 producido hasta 1966 llegaría el coche de Honda seguramente más importante para la marca: El Civic. Un coche que en sus 11 generaciones se acerca a los 30 millones de unidades fabricadas. Fue un coche importante en Japón, en Europa, donde Honda estaba desde 1962, pero sobre todo en Norteamérica, donde supuso realmente el lanzamiento de la marca. Porque el Civic era un coche de una calidad increíble, un consumo muy ajustado y a muy buen precio. Y es que en todos los coches Honda se nota que la marca es especialista en motores y en motores de moto, más refinados, ligeros y potentes que los de los coches, a igualdad de cilindrada, por razones que son obvias. En los años 80 la marca lanza multitud de modelos, entre otros el CRX, el Legend o el Concerto y los motores con tecnología VTEC, de los cuales tenéis video titulado “Los motores VTEC de Honda, ¿mejor que el turbo?”. Ya sabéis que en las marcas hay coches que son los encargados de hacer grandes ventas y ganar dinero y otros que son un escaparate tecnológico, una muestra de lo que puede hacer la marca, y que son también muy importantes, aunque su ventas sean reducidas. En el caso del Honda este coche es el NSX que marcó un antes y un después para la marca. De este modelo hemos hecho varios vídeos así que no me extenderé mucho, pero sí hay que decir que situó a Honda como una de las marcas con tecnología más avanzada… bueno, y los resultados en F1 también ayudaron… Como en otros vídeos de historia de las marcas de la parte más reciente no hablo porque es más conocida… aunque si queréis saber cómo evolucionó Honda desde los 90 hasta ahora… que se une a Nissan y Mitsubishi…

What is going on everyone and welcome back to TT! This week, I am joined by Ryan Kristoff. Ryan is a veteran amateur racer (his own words but he's better than that) who's been racing in Gridlife for over a decade plus. This is an old school of episode of TT which takes us back to our passion of grass-roots motorsports and we dive into what makes it so special. We chat about Gridlife itself, fast Hondas and what makes them so cool in particular his awesome CRX race car, why he enjoys wheel to wheel racing over doing hot laps, his dad being into old school Euro cars while growing up in the midwest and so much more. It's an awesome chat and Ryan is an awesome. Make sure you give him a follow on IG @ryankristoffracing. Enthusiasts never die!

In tonight's show the dads kick off with a little catch up, a little Canada chat, a little January chatter, and then they'll move on to parent funny tweets about housecleaning. Then onto the smart articles by smart people section with tonight's article “The Secret to Living a Happy and More Fulfilling Life” and then they have a quick quiz on How often should you wash the sheets? The dishtowels? The rugs? The dog bowl? Take our cleaning quiz, we bet you'll be surprised.  Plus MK gets stuck in Canada, CRX doesn't wash his dog bowl, Ben carries coal in his car, Mark uses a crystal for deoderant  and the guys fully breakdown the art of dishwashing. We're not parenting experts, but we listen to them, we interview them, we read what they have to say and then report back to you and ourselves to see how we're doing. It's a place to put your feet up or down relax, listen and let us do the legwork, research and reading. All articles, interviews and show notes are now available at www.dadtimeoutshow.com  

Find us on social media for daily content and information regarding all things music industry Twitter: https://twitter.com/soundcentricmus Instagram:https://https://www.instagram.com/soundcentricmusic/ Tik Tok: https://www.tiktok.com/@soundcentricmusic Facebook: https://www.facebook.com/SoundCentricmusic Website: https://soundcentricmusic.com Podcast: https://www.soundcentricmusic.com 00:00:00 - Intro  00:01:45 - How Tyler got his start for CQCX 00:04:50 - Tyler's top 10 album covers ever 00:08:35 - Tyler's new merch  00:09:30 - Thoughts on TLOP and Donda covers 00:12:15 - Adam's top 10 album covers ever 00:19:15 - Tyler's early influences  00:21:15 - The issue with "design by committee" made art  00:22:00 - Album cover trends that should stop 00:24:00 - The importance of the right font 00:24:45 - How Tyler collaborates with artists to make covers 00:27:45 - Connecting music to specific colors  00:28:35 - Dealing with impostor syndrome as a freelance artist 00:33:00 - CRX belief in Tyler 00:34:25 - Tyler's dream collaborations  00:36:30 - Our favorite concert moments  00:42:00 - Dreamville has cultivated a top tier fan base 00:47:30 - Our playlist titles of the week 00:48:30 - Closing thoughts  

From gasoline powered vehicles to hydrogen cells, the propaganda would tell you that America has a love affair with oil. The reality is that global warming is just a political tool used to further political ideologies that fuel campaigns. There is no global warming there never has been. If there was the government would long ago have banned the use of gasoline in our country, just the way they did and the Edison light bulb. You no longer see gas filled light bulbs in the grocery store, instead you see LEDs that last shorter than any bulb ever did. The reality is they have scammed us into believing backwards science. They have used terminology to make us believe that hydrogen cars are inefficiet. They have dumped electric vehicles onto the public that are disposable after just a few years. Power sells depleted and useless. And somehow we're supposed to believe that 40 years after the first CRX came out at 80 plus MPG on highway, are electric and hybrid vehicles can only get 20 MPG. Somehow we have become less efficient have producing efficient vehicles despite catalytic converters, recycling emissions, and precise computer systems installed in our vehicles. No our fuel injected 21st century vehicles get less MPG than an inefficient carburetor of the 1970s. Let's take a good look at some of the alternative vehicles out there part 2Support this podcast.Become an insider member & receive access to insider info, ad free episodes, and a free pdf copy of "If It's Broken Don't Fix It" By Mr Noriega once you join. Plus free access to questions and upcoming episodes. https://patreon.com/professorzero?utm_medium=clipboard_copy&utm_source=copyLink&utm_campaign=creatorshare_creator&utm_content=join_link https://www.barnesandnoble.com/w/if-its-broken-dont-fix-it-sinhue-noriega/1116503700?ean=2940149097692 If you can't afford a copy, just ask and a copy will be sent to you norcomwest@yahoo.com

From gasoline powered vehicles to hydrogen cells, the propaganda would tell you that America has a love affair with oil. The reality is that global warming is just a political tool used to further political ideologies that fuel campaigns. There is no global warming there never has been. If there was the government would long ago have banned the use of gasoline in our country, just the way they did and the Edison light bulb. You no longer see gas filled light bulbs in the grocery store, instead you see LEDs that last shorter than any bulb ever did. The reality is they have scammed us into believing backwards science. They have used terminology to make us believe that hydrogen cars are inefficiet. They have dumped electric vehicles onto the public that are disposable after just a few years. Power sells depleted and useless. And somehow we're supposed to believe that 40 years after the first CRX came out at 80 plus MPG on highway, are electric and hybrid vehicles can only get 20 MPG. Somehow we have become less efficient have producing efficient vehicles despite catalytic converters, recycling emissions, and precise computer systems installed in our vehicles. No our fuel injected 21st century vehicles get less MPG than an inefficient carburetor of the 1970s. Let's take a good look at some of the alternative vehicles out there part 1.

From gasoline powered vehicles to hydrogen cells, the propaganda would tell you that America has a love affair with oil. The reality is that global warming is just a political tool used to further political ideologies that fuel campaigns. There is no global warming there never has been. If there was the government would long ago have banned the use of gasoline in our country, just the way they did and the Edison light bulb. You no longer see gas filled light bulbs in the grocery store, instead you see LEDs that last shorter than any bulb ever did. The reality is they have scammed us into believing backwards science. They have used terminology to make us believe that hydrogen cars are inefficiet. They have dumped electric vehicles onto the public that are disposable after just a few years. Power sells depleted and useless. And somehow we're supposed to believe that 40 years after the first CRX came out at 80 plus MPG on highway, are electric and hybrid vehicles can only get 20 MPG. Somehow we have become less efficient have producing efficient vehicles despite catalytic converters, recycling emissions, and precise computer systems installed in our vehicles. No our fuel injected 21st century vehicles get less MPG than an inefficient carburetor of the 1970s.

Amy Ward teaches from 1 Corinthians 12 teaching on the gifts of the Spirit and answers questions from the CRX about how to operate in them. She defines the gifts of knowledge, discernment of spirits, the gifts of power, and the vocal gifts and goes through how each one operates and their purpose in the body of Christ. Amy talks about how we can let our presumptions about how the Holy Spirit operates can get in the way of the Holy Spirit and she teaches the CRX how to operate in each gift in a way to represent Jesus rightly. It is an important lesson on how to be a human and operate in the power and knowledge of the Holy Spirit by loving well and making mistakes.

Amy Ward teaches from 1 Corinthians 12 teaching on the gifts of the Spirit and answers questions from the CRX about how to operate in them. She defines the gifts of knowledge, discernment of spirits, the gifts of power, and the vocal gifts and goes through how each one operates and their purpose in the body of Christ. Amy talks about how we can let our presumptions about how the Holy Spirit operates can get in the way of the Holy Spirit and she teaches the CRX how to operate in each gift in a way to represent Jesus rightly. It is an important lesson on how to be a human and operate in the power and knowledge of the Holy Spirit by loving well and making mistakes.

Amy Ward teaches from 1 Corinthians 12 teaching on the gifts of the Spirit and answers questions from the CRX about how to operate in them. She defines the gifts of knowledge, discernment of spirits, the gifts of power, and the vocal gifts and goes through how each one operates and their purpose in the body of Christ. Amy talks about how we can let our presumptions about how the Holy Spirit operates can get in the way of the Holy Spirit and she teaches the CRX how to operate in each gift in a way to represent Jesus rightly. It is an important lesson on how to be a human and operate in the power and knowledge of the Holy Spirit by loving well and making mistakes.

Amy Ward teaches the CRX how the Holy Spirit is God and who he is and where he appears throughout the scriptures. She brings the school of the reality of waiting and experiencing the Holy Spirit fall at Pentecost. She then teaches about the attributes of the Holy Spirit in the Bible and how he can operate in our daily lives.

Amy Ward teaches the CRX how the Holy Spirit is God and who he is and where he appears throughout the scriptures. She brings the school of the reality of waiting and experiencing the Holy Spirit fall at Pentecost. She then teaches about the attributes of the Holy Spirit in the Bible and how he can operate in our daily lives.

Amy Ward teaches the CRX how the Holy Spirit is God and who he is and where he appears throughout the scriptures. She brings the school of the reality of waiting and experiencing the Holy Spirit fall at Pentecost. She then teaches about the attributes of the Holy Spirit in the Bible and how he can operate in our daily lives.

Matt Nelson teaches the CRX about the importance of taking authority over words and phrases that come out of our mouths. He teaches us how powerful speaking words of life are in spiritual warfare and how dangerous words of death can be. 

Matt Nelson teaches the CRX about the importance of taking authority over words and phrases that come out of our mouths. He teaches us how powerful speaking words of life are in spiritual warfare and how dangerous words of death can be. 

Matt Nelson teaches the CRX about the importance of taking authority over words and phrases that come out of our mouths. He teaches us how powerful speaking words of life are in spiritual warfare and how dangerous words of death can be. 

In this PI 3.14 Episode, Mental learns to drive a stick on his dads lap, Chris learns to drive in Fiat Fiorino and Chrissy learns to drive in a broken down VW.  Really, we talk about experiences when learning to drive, both ours and the tales you shared!  So many great stories! FIA Approves Andretti F1 Bid https://www.motorsport.com/f1/news/fia-approves-andretti-application-for-11th-f1-team-slot/10527925/ 35 CRX's for sale in Arizona.   https://grassrootsmotorsports.com/news/you-need-this-35-yes-seriously-honda-crxs/?utm_content=buffer10d78&utm_medium=social&utm_source=facebook.com&utm_campaign=GRMFacebook&fbclid=IwAR0GyZ3InS5uqMEk7Ze5J5cYHbmxu9Xbm3qNWzXmsv8LS3DhJez54gaKQVU_aem_AeRQF3kLawpOJcqY_fra5vU-JBa6u7-RFnjtVnJsc__I6m3-jzcw_2UVzVJLkViTCH4 https://www.facebook.com/marketplace/item/1759514717887215/?mibextid=IouU6C 2002 Nissan Sentra for only $1500 on Racing Junk   https://www.racingjunk.com/nissan/184457073/2002-nissan-sentra.html?category_id=1056&photos=&location_distance=1000&location_zip=&year_min=&year_max=&price_min=&price_max=&seller_type=&condition=&state=&order=price-low-high&np_offset=87&from=search Fiat Fiorino https://en.wikipedia.org/wiki/Fiat_Fiorino#/media/File:1983_Fiat_Fiorino_Furg%C3%A3o.jpg The Leader's Mindset on Apple Podcasts https://podcasts.apple.com/us/podcast/the-leaders-mindset/id1701276142 Buy the Corvette! ⁠https://www.hagerty.com/marketplace/auction/7LycPNicvtPYbj1mcBRna?fbclid=IwAR0KHC__pdy_Eu1gQWNwzr6xa-BOsAOK4juK0R76WL1-T0zjSdWrlNK4RPk  Vote for Tracy Guadu https://hoosiertire.com/HoosierHeroes/vote.cfm?fbclid=IwAR29Bdl7SIgi3PytZSFPW8sM_sYFoRl_O0og68uQDAJwaKswDYDwbDc3p4c E1R at Glacier Bay Car Launch ⁠https://youtu.be/rkLtmPxFGIE⁠ Mental and Chrissy Try Malort ⁠https://www.instagram.com/p/CtDac5-Ix-n/⁠ Chrissy's World Famous F* Bisquick Recipe ⁠https://youtu.be/83c3rjGqEeQ⁠ Play F1 Fantasy with us!  ⁠https://fantasygp.com/league/?lid=8094⁠ “Join a League” = 38648094 Our Website -⁠ https://everyoneracers.com/⁠ Download or stream here -⁠ https://open.spotify.com/show/5NsFZDTcaFlu4IhjbG6fV9 ⁠https://mfbc.us/m/yp26k6j⁠ - E1R Bingo Card ⁠https://discord.gg/e94QGE⁠ - E1R Discord Server  ⁠https://www.youtube.com/channel/UCPrTs8wdzydOqbpWZ_y-xEA⁠  - Our YouTube

Zach Nash teaches from the Culture Shift Manual about the Culture of a Radical Servant to the Fall 2023 CRX.

Nick Brennt leads the CRX through their first session of the Culture Shift Manual, beginning with the Culture of a Faith Filled Life.

Nick Brennt leads the CRX through their first session of the Culture Shift Manual, beginning with the Culture of a Faith Filled Life.

Zach Nash teaches from the Culture Shift Manual about the Culture of a Radical Servant to the Fall 2023 CRX.

Zach Nash teaches from the Culture Shift Manual about the Culture of a Radical Servant to the Fall 2023 CRX.

Nick Brennt leads the CRX through their first session of the Culture Shift Manual, beginning with the Culture of a Faith Filled Life.

In this episode of No Driving Gloves, hosts John Viviani and Brian discuss the changes in buying used cars over the years, from the availability of information to the rise of online marketplaces. They also touch on the evolution of car-related media, from the early days of podcasting to the explosion of car content on YouTube. Plus, they consider bringing back their "This Day in Automotive History" segment in a new format. Tune in for some automotive nostalgia and insights![00:01:47] Elite team of car sniffers.[00:06:13] Day in automotive history.[00:08:48] Online car auctions.[00:14:14] Online car buying.[00:17:07] eBay's growth and history.[00:20:47] Instant gratification culture.[00:24:24] Buying used cars on Craigslist.[00:27:45] Word of mouth car buying.[00:32:30] Online car auctions and archives.[00:37:21] Rise of collector car values.[00:41:41] Collectible Cars Increase in Value.[00:44:06] Cash for clunkers and collectible cars.[00:50:18] Expenses Proportionate to Income.[00:52:16] Reasonable prices for cars.buying cars, secondhand, lifetime, Audi, sniffers.,smell, nostril, cigar, podcast, automotive history,automotive history, No Driving Gloves, window shopping, Craigslist, eBay auctions.,Craigslist, internet, cars, trading post, appointment.,eBay, online car buying, discussion forums, CRX, Web TV,eBay, auction, bring a trailer, data, Lotus.,car, ad, phone, digital cameras, sales,Craigslist, Facebook, buying, cars, Lotus.,pre-purchase inspections, Craigslist, word of mouth, beater, third party.,deals, appraisals, cars, word of mouth, Facebook Marketplace,bring a trailer, website, auctions, cars, sales,car, VIN numbers, bring a trailer, imported cars, comments.,Toyota Corolla, auction, community, collector car values, muscle cars.,home equity cars, borrowing, car prices, auctions, eBay,low mileage, CRX, Integra Type R, buying cars, affordability,collectible, rental cars, obscure vehicles, used cars, knowledge base.,conversation, collectible, prices, money, dealership,expenses, income, cars, financing, prices,bring a trailer, collector car auctions, worth, bid, No Driving Gloves Network

In this episode of No Driving Gloves, hosts John and Derek discuss imposter syndrome and their backgrounds in car knowledge. They also discuss their favorite cars and the importance of experience and controversy in the world of car talk. The hosts are joined by Gary, who gives a unique introduction to the show.[00:02:21] Imposter syndrome and car knowledge. [00:06:24] Imposter syndrome in cars. [00:09:01] Finding a career-defining moment. [00:13:48] Labeling oneself as "car guy". [00:16:48] Imposter Syndrome in Career. [00:21:01] Pickup truck vs Mustang rivalry. [00:26:22] Being humble in car restoration. [00:29:01] Working on rare cars. [00:33:30] Expensive 1952 Cunningham cars. [00:36:27] Imposter syndrome in restoration. [00:43:00] Hemmings and Lotus Seven. [00:45:39] Professionalism in speaking. [00:50:46] Revamping the podcast. {00:54:22] Falling in love with cars.cars, Ferrari, GTO, Bentley, CRX, live streaming, schedules, cars, knowledge, technical glitches, car magazines, personality, imposter syndrome, public speaking, car career, conservation, cars, museums, imposter syndrome, behind the scenes, career, computers, business, podcast, imposter syndrome, museum professional, car passion, nonprofits, PR, conservation, imposter syndrome, background, car shows, car modifications, quiet car, Ford Courier, Grand National Motor, IndyCar, volunteer staff, professional., shop, car, history, humility, learning, learning, museum, automobiles, Viper, restoration, restoration, cars, C3, imposter syndrome, Cunningham, imposter syndrome, car restoration, TR6, reproduction, restoration techniques, restoration, imposter syndrome, Chrysler CM6, top insert, research, long grain, material, construction processes, museum background, original.,magazine, Lotus Seven, advertising, business, honesty, knowledge, backgrounds, consulting, car, trust, care, podcast, revamp, store, email list, editing, tell a friend, podcast, cars, social media, Ferrari, cars, No Driving Gloves, automotive family, car guy.

00:00 - INTRO: The 60+ MPG Commute-Crushing HybridIf I wanted a used vehicle that gets amazing fuel economy at a far more reasonable price than a used Tesla, I would buy the first hybrid sold in the US. It's a vehicle that had an amazing EPA fuel economy rating and it's a car I still geek out over today, in spite of the fact that the earliest examples are more than 20 years old and they're not exactly fast. In fact, I'd say they're more… funky. And no, it's not a Prius, but I'll tell you what it is and why you might want one in just a moment, so hop in, buckle up and let's go for a drive! 01:20 - OPEN – Hybrid Technology Offered The Best Fuel Economy In The Early 2000'sToday it's electric vehicles, but 20+ years ago, if you wanted great fuel economy, you had to get a hybrid. The Prius was the first one to be launched in 1997, but it was a Japan-only model for the first couple of years and it wouldn't come to the US until model year 2000. 02:25 – The 2000 Honda Insight – The First Modern Hybrid Vehicle Available In The USIn spite of Toyota's Prius being the first mass-produced hybrid, Honda beat the Prius to American soil with the introduction of their first Hybrid, the 2-seat Honda Insight. While the Prius had impressive fuel economy, the Insight crushed it with a 61-city and 70-mpg EPA highway MPG rating. 03:35 - 2000-2006 Honda Insight is a more modern interpretation of the 1980s Civic CRX HFIntroduced in 1984 to the US market, the Honda CRX was a sporty, lightweight, front-wheel drive, 2-door hatch back that in its highest horsepower configuration (the CRX Si) offered sports car like performance that could give a comparable year Toyota's MR2 or Pontiac's V6 Fiero a run for their money. But in addition to the Si model, Honda also offered an HF or high fuel mileage version of the CRX that was equipped with a more fuel efficient engine and taller gearing to improve fuel economy. For comparison, the base model 1984 CRX with a 1.3-liter 4-cylinder engine and a 5-speed manual transmission has a revised EPA fuel economy rating of 38 city / 48 highway and 41-mpg combined. That's better highway mileage than the first Prius and matches the combined Prius rating of 41 mpg… without the complication of a hybrid power train. Of course, the CRX was much lighter because it was a smaller 2-seat vehicle, plus it didn't have to meet model year 2000 crash standards. But still, the fuel economy of the 1.3-liter 1984 CRX was impressive. Fast-forward 16-years and the 2000 Honda Insight Hybrid expanded on those numbers with even more impressive fuel economy. When first introduced, the EPA rating for the Insight was 61-mpg city / 70-mpg highway and 65 MPG combined. Those numbers were later revised to 49-city/61-highway/53-mpg combined. Yet even the revised EPA fuel economy estimates for the First Generation Honda Insight are impressive by today's fuel economy standards. So if that piques your interest, let's get into why you might want a 2000-2006 First Generation Honda Insight. 05:45 - You Might Want A First-Generation Honda Insight If… You want a car that gets amazing fuel economy, especially for a long-distance daily commute, but you don't want to pay the price required to buy a new or even a used EV with decent driving range between charges. You don't need to carry more than one extra person and a small amount of gear. So the big hold-back on the First Gen Insight for many was seating capacity. It has 2-seats with about 5-cubic feet of space to store items under the rear...

Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2023.03.01.530650v1?rss=1 Authors: Occelli, L. M., Tran, N. M., Chen, S., Petersen-Jones, S. M. Abstract: PURPOSE. Human mutations in the CRX transcription factor are associated with dominant retinopathies often with more severe macular changes. The CRX-mutant cat (Rdy -A182d2) is the only animal model with the equivalent of the critical retinal region for high acuity vision, the macula. Heterozygous cats (CRXRdy/+) have a severe phenotype modeling Leber congenital amaurosis. This study reports the distinct ocular phenotype of homozygous cats (CRXRdy/Rdy). METHODS: Gene expression changes were assessed at both mRNA and protein levels. Changes in globe morphology and retinal structure were analyzed. RESULTS: CRXRdy/Rdy cats had high levels of mutant CRX mRNA and protein. The expression of photoreceptor target genes was severely impaired while there were variable effects on the expression of other transcription factors. The photoreceptor cells remained immature and failed to elaborate outer segments consistent with the lack of retinal function. The retinal layers displayed a progressive remodeling with cell loss but maintained overall retinal thickness due to gliosis. Rapid photoreceptor loss largely occurred in the macula-equivalent retinal region. The homozygous cats developed markedly increased ocular globe length. CONCLUSIONS: The phenotype of CRXRdy/Rdy cats was more severe compared to CRXRdy/+ cats by several metrics. TRANSLATIONAL RELEVANCE: The CRX-mutant cat is the only model for CRX-retinopathies with a macula-equivalent region. A prominent feature of the CRXRdy/Rdy cat phenotype not detectable in homozygous mouse models, was the rapid degeneration of the macula-equivalent retinal region highlighting the value of this large animal model and its future importance in the testing of translational therapies aiming to restore vision. Copy rights belong to original authors. Visit the link for more info Podcast created by Paper Player, LLC

In this episode we talk about Crunchyroll Expo 2022 and 2023. CRX is an annual three day anime convention at the San Jose McEnery Convention Center in San Jose, California over Labor Day weekend. Help support Panel to Panel: www.patreon.com/paneltopanelpodcast www.ko-fi.com/paneltopanel Hit up the Panel to Panel team at: paneltopanelpodcast@gmail.com  Twitter @paneltopanelpod Instagram @paneltopanelpodcast

With 33 years in the car audio and security industry, John Schwartz is an icon in the 12v world. His love for the industry started at 14 years old when he was working next door to a car audio shop. He can still remember the day a guy pulled up in his CRX and turned on the bass. With every window in the place shaking, John was intrigued. He immediately went into the shop and begged for a job. He started off just sweeping floors and cleaning bathrooms, but soon got to help with installs and learned the trade. At 16, John's family moved to Alaska, and John became the stereo guy at school. People started calling John the ‘Sound Doctor' and so he decided to get his first business license under that name. At 18, John got hired at Safe & Sound, but continued to do installs on the side. Eventually he went full time and rose through the ranks. With tons of other shops hitting John up to run theirs, John's boss wouldn't let him quit until he considered it a worthy job. That finally happened when the owner of CompuStar Auto Security asked for John's help in beating out Viper. As head tech, John was helping to develop new products. However, his boss also owned Perfectionist Audio, and wanted John's help to figure out why the business wasn't succeeding. John was sent to Perfectionist to be a spy but eventually fired the whole team and started over as the shop manager. When CompuStar moved to Seattle, John was asked to come along, but when he heard that would be the end of Perfectionist, he asked to stay. John's goals with the company included winning retailer of the year and buying the business from his boss, all before his 35th birthday. The first few years were rough, but in 2006 he built a new building and started pushing hard for that million dollar goal. John brought the company through the economic collapse of 2009, and by 2010 was up for retailer of the year. A few hours before the awards, John's boss told him he was thinking of selling the business. Thirty minutes later, the two had worked out a deal for John to be the buyer. Later that evening, Perfectionist would win retailer of the year. Both of John's goals were realized three weeks before his 35th birthday. Continuing to also work for CompuStar, John pitched the Australian market in 2015. CompuStar was so busy though, they told John he could be in charge of the Australian market. Next thing John knew, he had picked up 100 stores and was expanding into New Zealand and S. Africa. At the same time, John was developing a new sound deadening product, SoundSkins. Now, as an international distributor, retailer, manufacturer, and wholesaler, John was on top of the world. The cherry on top was winning retailer of the year for the second time. To celebrate, John's partner bought him the first 100 tubes of SoundSkins. John decided to send one to each big installer to get their name out there. John's plan was working, but his business partner got impatient and things started to get shady. This caused John to walk away from SoundSkins. A couple years down the road though, John would start another sound deadening manufacturing company on his own, called SoundShield. What You'll Learn: How Perfectionist Audio broke their first million. What the blue ocean theory is. Why John walked away from SoundSkins. What the value equation is and how it works. Favorite Quote: “A lot of times as business people, we forget that moment that got us into the industry.” -John Schwartz How to Get Connected: Perfectionist Auto Sound Facebook

Der Honda CRX Serie 2 – Die neue japanische Sportlichkeit Bis zum Erscheinen des Honda CRX der Serie 2 waren sportliche Japaner in Deutschland eher die Seltenheit, wurde sogar politisch inkorrekt als „Reisschüsseln“ verlacht. Als dann der CRX ED9 bzw. EE8 ab 1987 auf den Markt drängte, lachte niemand mehr, schon gar nicht die Angehörigen der GTI / GSI-Fraktionen. Mit Regelmäßigkeit wurden die heimischen Volkssportwagen jetzt von den CRX „zersägt“ und auch die so oft kritisierte Reparaturanfälligkeit der Autos aus Fernost gehörte ganz nun der Vergangenheit an. Ganz im Gegenteil, das äußerst drehfreudige Vierzylinder-Aggregat, mit 150 PS in der höchsten Ausbaustufe, gilt noch heute als langlebig. So sind 300.000 Kilometer Laufleistung überhaupt keine Seltenheit. Trotzdem ist schnell klar: Das Auto ist nichts für Warmduscher. Der Honda profitierte von den Erkenntnissen aus der Entwicklung des Sportwagens NSX und den Erfahrungen im Motorradmotorbau, hat allerdings Vorderradantrieb und keinerlei aktive oder passive Fahrhilfen. Wer also auf ABS oder sonstige Unterstützung hofft, wird schnell eines Besseren belehrt. Der CRX ist fahrtechnisch die reine Lehre. De Stoßdämpfer waren in der Serie ein Schwachpunkt, weshalb der sportlich ambitionierte CRX-Pilot auf gelbe Konis umrüstete. Und der Grenzbereich ist wegen des kurzen Radstands äußerst schmal. Und so flogen ziemlich viele halbstarke postpubertäre Möchtegernrennfahrer in den 80ern und 90ern mit dem CRX ab. Der Honda wurde zudem das Opfer unfassbarer Tuning-Sünden. Vor allem der riesige Auspuff von der Firma Mohr dürfte in Erinnerung geblieben sein. Der Legende nach hat er zahllose Katzen und anderes Getier zum Übernachten eingeladen und sorgte bei den armen Tieren dann wohl am Morgen für einiges Ohrensausen. Nur vier Jahre, also bis 1991, wurde der CRX der Serie 2 gebaut. So sind originale und vor allem gute Exemplare heute rar, vor allem mit den großen Motoren. Doch man findet sie und wer jenseits von GTI und GSI auf der Suche nach einem sportlichen Coupé der späten 80er Jahre ist, dürfte am CRX wohl kaum vorbeikommen. Oli, Ron und Fredo sind sich mal wieder uneins. Während Fredo die Serie 1 in jedem Fall vorzieht und schöner findet, glänzt Olli mit Desinteresse an beiden Serie. Für Ron sollte es ein ED9 sein, wegen der Hutze auf der Haube, natürlich ohne KAT und mit 130 PS. Als er sich dann noch ein getuntes Exemplar wünscht mit ordentlich Plastik und dem Mohr Katzenschreck-Auspuff rollen Frederic und Oli mal wieder mit den Augen. Was das alles mit Schmuggelfächern, Verwindungssteifheit und Unfallfahrzeugen zu tun hat – das erfahrt ihr in diesem Podcast. Foto (c) Honda Auch wenn Weihnachten schon wieder rum ist, besucht doch unseren Fan Shop unter https://www.classicpodcars.de/shop und unterstützt unser Projekt durch den Erwerb unserer "Nette Menschen" Merch-Artikel! Wenn ihr auch einen Wunsch für ein Auto habt oder uns konstruktive Kritik zukommen lassen wollt, dann schreibt uns einfach eine eMail an nettemenschen@classicpodcars.de Wenn euch unser Podcast Projekt gefällt, dann gebt uns einen Daumen hoch, abonniert uns auf Sportify, Amazon oder Apple und empfehlt uns euren Freund:innen, ihr findet uns überall dort, wo es gute Podcast gibt, auf Insatgram unter @classicpodcars oder auf Tiktok.

Now that conventions are done for the year, we take a moment to look back on the year and see which were the good, bad and TERRIBLE. What was your favourite convention this year, did it make our list? CRX... Crunchyroll Expo Aus, Oz Comic Con, Supanova, Sydney Smash and Akacon! Which conventions will you add to your bucketlist next year? Did you know you can also listen to our podcast on while you're on the go? Spotify ➡️ https://spoti.fi/3NkLXCl Google Podcasts ➡️ https://bit.ly/3DLzGDP Apple Podcasts ➡️ https://apple.co/3T7GJLz   find us- https://linktr.ee/justbecos.cast follow us online c: jeremy - https://linktr.ee/mangalphantom marmalade - https://marmaladecos.carrd.co/  

FANUC is the global leader in robotics and CNC controls technology - and we sat down with FANUC America's President & CEO Mike Cicco at IMTS 2022 to dive into the latest trends in automation.3 Big Takeaways from this episode:1. AI and Digital Twins will have a huge impact on automation in the next few years: Like many industrial OEMs, FANUC is turning to software innovation to enhance its world-leading hardware offerings. Right now, R&D is focused on artificial intelligence and digital twins. AI enables companies to take technically challenging tasks - like bin picking miscellaneous objects or assembling parts with multiple moving pieces - and makes it easier to program a robot to do them. Digital twins enable engineers to build new automation lines and processes and fully test them in a digital environment before implementation.2. Collaborative robots (like the FANUC CRX) are making industrial automation more accessible for small-to-midsize companies: Collaborative robots (cobots) are built to inherently work side-by-side with humans. But the real benefit, as Cicco shares with us, is how the CRX is designed for simple, lead-through programming. The implication for employers is huge: programming robots and machine tools for complex tasks (including high-mix, low-volume) has never been more accessible. Now, small-to-midsize companies can more easily and rapidly adopt and deploy advanced automation into their facilities.3. Demand for automation has led FANUC to expand its physical space and training programs: Changes to supply chain, manufacturing moving back to the U.S., and the two points above have led to a rise in demand for automation technology. In response, FANUC has expanded its manufacturing capabilities at its American headquarters in Michigan, along with expansions in Mexico. The new physical space will increase their manufacturing capabilities, but will also increase capacity for training individuals in the workforce around these technologies.Note for educators: FANUC's education programs have led the market for years (1,500 CERT schools and counting), but with demand for robotics and CNC programming skills on the rise, it's a good time for educators to consider how they can prepare their students for these career opportunities.ResourcesEmployers, to learn more about FANUC America robotics & CNC solutions, visit: https://www.fanucamerica.com/Educators, to learn more about FANUC's robotics & CNC education and training solutions, visit: https://www.fanucamerica.com/educationYou can access our first episode with Mike Cicco here: Episode #6: Why Schools Should Teach Industrial Robotics & AutomationConnect with FANUC America on social media:Facebook  |  Twitter  |  Instagram  |  YouTube  |  LinkedInEpisode page: https://techedpodcast.com/fanuc/Instagram - Facebook - YouTube - TikTok - Twitter - LinkedIn

This week's guest is Ralph Alexander…an incredibly talented drummer currently out with the artist Poppy. Ralph is one of those “rarely makes a mistake” kind of drummers, but his incredible independence was the first thing that turned me onto his skills…referring to this video. I mean…wow.  He's also worked with other legendary artists including CRX (featuring Nick Valensi of The Strokes). Anyways, just trust me, he's great. Please enjoy this chat about the 5 records that shaped him into the bombastic yet incredibly precise drummer he is today.  For more information on Big Fat Snare Drum, check out www.bigfatsnaredrum.com and follow us on Instagram, Facebook, Twitter, and TikTok

Mistress Carrie – You may know her from the Mistress Carrie Podcast, Cocktails in the War Room, & the Mistress Carrie Radio Show. She was on WAAF in Boston for 22 years (1998-2020), and can be now be heard on 100FM The Pike in Worcester MA, around the U.S. on Westwood One's Rock 2.0 and CRX stations, and around the world on the American Forces Network. Carlota Gonzalez is a radio DJ. She worked at Xtreme Radio, She was on KOMP 92 for 18 Years, and recently signed on with 98 Rock in Sacramento.

A legend in The Honda Challenge community and there from the start of it here in the west coast, Andy Hope. From his iconic CRX build to working for Honda as a driver and Helping with the Porsche experience here in LA. Mr. Hope about working with past guest like Joe Alaniz and old roommate Tom Paule. And if you are looking to learn how to paddle board in the Marina Del Ray area look up Pro sup shop. and stay tuned for the stones when they come out. Thank you again to Mr. Hope.

This title has very little to do with what we're talking about, but Cory does have a weird story about Bluey The Dog and Attack On Titan. The main focus of the episode however is this. With Anime Expo and CRX both concluded we have a whole ton of new trailers, teasers, and generally exciting announcements for new and returning shows. We've mentioned a lot of new titles as they get new info, so this episode is all about the new season of returning titles we are hyped for. We've got a pretty stellar lineup next season as well as seasons yet to come, but which titles are we most excited about? Let's find out! 

Cruz and Sal are back this week with some INCREDIBLE NEWS: You can catch the two of them at Crunchyroll Expo 2022, where they'll be covering the convention officially as press! Expect a cavalcade of news and updates starting Thursday, August 4th through Sunday, August 7th, as well as additional post-con coverage in the following weeks! After we talk Crunchyroll, we drop reviews for "Call of the Night", "The Yakuza's Guide to Babysitting", and "Lycoris Recoil"! The Nakama Podcast is supported by the community on Patreon! Lyn's latest My Hero Academia article! (0:00) Intro (2:10) Press @ Crunchyroll Expo 2022 (4:07) Sal meets Masahiko Minami of Studio Bones & Baku Kinoshita of ODDTAXI (5:05) We're meeting Kureiji Ollie & Anya Malfissa of Hololive! (7:30) Cruz likes foreign bands he can't even understand (8:34) We're excited for CRX (12:39) Cruz loves girls who speak other languages (14:49) It's the "Oops! All Bangers!" episode (15:14) Lycoris Recoil REVIEW (26:02) Yakuza's Guide to Babysitting REVIEW (32:24) Call of the Night REVIEW (42:41) Lyn's lates MHA article! (44:53) Cruz's latest article! (45:55) Outro! Find more about the podcast, as well as news and reviews over on our website!

In today's PorscheCooled Podcast Michael presents episode 78 of Owner Stories with Freddie from Toronto, Canada. Freddie started noticing Porsches from a young age. He had the poster on the wall of the iconic 930 Turbo and its whale tail. He also remembers a 964 commercial shown on Canadian TV in the ‘90s showcasing all the unique Porsche 911 colours of the time. Freddie like most of us didn't start with a Porsche, he was heavily into Hondas and still owns one today. His first car was a 1990 Honda CRX Si a car he modified and made just that little bit better. Freddie mentions early on that he is a ‘90s guy and pretty much all the cars he has owned are from the 1990s and later. So, after the CRX the cars that followed included many Hondas, BMWs, Toyotas, Acura's and even a Lexus. Freddie's third Honda CRX purchased in 2007 he still owns and sits under a cover in his garage. Apart from his current four Porsches Freddie also has a couple of daily drivers. These include a BMW F80 M3 and a E90 335i as well as his ‘winter daily' a Volkswagen Sportwagon. As you can see Freddie loves his cars. Now for the Porsches. The first 911 came in 2002 when Freddie and his wife purchased a brand new 911 - a 996 Carrera 2, white on tan with aero package. A big jump from the Hondas and Freddie recalls that at the time he and his wife felt like they were ‘driving the fastest car in the world.' A fun car, but after 6 years of ownership Freddie wanted something more. A bigger jump followed in 2008 when Freddie purchased one of the best 911s – a 2007 997 GT3RS in Orange. A car Freddie still owns.   Other Porsches owned which have now left the garage include a '91 964 911 Turbo, 997.1 Turbo, a 1990 964 C4. Oh, and the one he almost forgot to mention the 2010 low mileage GT3. So apart from the 997 GT3 RS what completes Freddie current line-up? Well, that would be a 997.1 Carrera 2S, a well sorted 964 Carrera 4 in the rare shade of Baltic Blue metallic as well as his 911 (991.2) GT3 Touring in Chalk. Freddie remains humble and acknowledges everything has just come together well - especially when his day job overlaps with his Porsche passion. He has a soft spot for 964's but just remember to ask two key questions before purchase – ‘is it leaking oil and does the Aircon work?' Welcome back to the PorscheCooled Podcast.   Follow Freddie on Instagram @911luv   Michael (@michael.bath) owns a first generation 997 Carrera, comes from Australia and currently resides in Bahrain. Steve (@gtst3ve) is a Porsche owner and enthusiast from Sydney, Australia. This podcast is part of a series with Steve where two mates chat about all things Porsche. Thanks for listening. PorscheCooled Exclusive member Become a member of PorscheCooled and help support the Podcast. It will keep us talking! https://www.patreon.com/porschecooled The PorscheCooled Podcast is available everywhere you get your podcasts.

Join Don Bruns as he sits down with some of our team members from Raven Europe. Thijs Esselink, Maurice Vollebregt, and Yeb Andela discuss the advanced features of the CRx platform since the European team is responsible for a lot of the development for the CR7 and CR12 field computers. Don't miss this great conversation!

In this, the 48th (but who's counting) episode of Bangers & Classics, we find out if Honda's pocket rocket from the 1980s has the, ahem, CRX factor. James waxes lyrical about an Alvis Parsley (I think that's the right name – this handwriting is harder to decipher than hieroglyphics) film and there's much chat about biscuits. Elsewhere, fresh from his defeat in last week's challenge, James ups the ante this week by finding an Italian car with plenty of space for golf bats whilst David's efforts to find a black phase 1 Renault 25 Turbo, and thereby become a yuppie, are frustrated.

Escucha el espacio musical para combatir los gérmenes todos los días a las 08:00 y a las 10:00 horas en compañía de Luis Diego Peralta. En este capítulo suena CRX, banda de rock estadounidense formada en Los Ángeles en el año 2013. Está integrada por Nick Valensi en la voz; Ralph Alexander en la batería; Brad Oberhofer en el teclado y en los coros; Jon Safley en el bajo y en los coros; Darian Zahedi en la guitarra y en los coros. Disfruta este podcast sonoro.

Episode Summary:Elon Musk Sells $5 Billion of Tesla Shares$500 Shiba Inu Giveaway Guests:Ben Rabizadeh StoryTrading 10:00Vivi Biotech Queen https://twitter.com/Biotech_SD 24:00Zandy Forbes, Ph.D. President & CEO of MeiraGTx (NASDAQ: MGTX) 41:00Ronen Samuel, CEO of Kornit (KRNT) 55:00Scott Mathis, CEO and Chariman of Guacho Holdings $VINO 70:00Renato Capelj, Benzinga, Physik Invest 110:00https://physikinvest.com/Hosts:Spencer IsraelTwitter: https://twitter.com/sjisraelAaaron BryTwitter: https://twitter.com/aaronbry5Subscribe to all Benzinga Podcasts hereClick here for BENZINGA TRADING SCHOOL Get 20% off Benzinga PRO here Become a BENZINGA AFFILIATE and earn 30% on new subscriptionsDisclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.Unedited Transcriptwe got a lot of guests today. Here's that's what I said. Here's what we got. We got Ben from story trading in like eight minutes. We've got Vivi biotech, uh, or the Bio-Queen at, uh, 1215. We've got Zandi Forbes from Mira GTX. She's a presidency yet.We're talking gene editing at 1230. We got Ronan Senor from Coronet digital we're talking, uh, fashion and the fashion supply chain at 1245. Did I get all that right? As far as timing goes. Yep. We got Scott Mathis from Gaucho holding sicker V I know, uh, at one and that Renato, uh, Capella, he is a Benzinger writer and also does some really, really cool options trading on the side.Uh, he'll be on the show at one 30. So we got what we got. 1, 2, 3, we got six guests today. We have all that's a lot, frankly. Uh, maybe a few too many, but nonetheless, here we are. So before we get to those guests, uh, we're going to talk about what's what's moving. We're going to talk about, uh, crypto. We're going to do a guest that sharp sediment.Cause we got some good feedback from that yesterday. So, um, AB where should we start? Um, well, let's start with just looking at the overall market. Spencer. I see Christian in the chat asking who do we have on for a guest today? You just ran through them, but you can also check the description in the YouTube, uh, the YouTube description for the guests for the day.Um, and shout out to the chat yesterday. We had some good trade ideas thrown out in the chat yesterday. We did, uh, easy Mike was talking about Uber puts. I played those. They were up nicely. Um, and we were talking about playing Disney for a big move on either side. We got talked out of it by our main man, Nick Shaheen.But yeah, I don't know. Maybe we should have done it. Yeah. I felt bad about that one going and they got talked out of it, but, uh, you know, it was a pretty brutal quarter. So, um, anyway, I don't even know why I look at Disney it's in my never sell portfolio. That's my first mistake is don't look at and stuff and your never sell portfolio.Otherwise you're just giving yourself anxiety. Rowan DAS pips is saying audio levels. Are we good, Bruce? Or Ron? Are you awake? I'm here. Okay. Oh, he's coming through us through the sky. I did not know that was coming from Terminator. I'm hanging out on the background, like a good idea. Hey, uh, while we figure out those levels, if you all want to do a solid, as DK suggested and hit that like button ladies and gentlemen, we'd appreciate that.Thank you very much. Um, Hey, what's do a guest, that chart segment. We're going to start doing this every day yesterday. Wasn't it easy one a B I don't even remember what it was. It was D whack. Oh yeah. That was that. That was yours. Full disclosure, I guess the one today. No, because I changed it. Shoot. So beforehand Spencer showed me the guests that chart and I guessed it and he didn't like the fact that I got it so easily.So he went out and picked a new one. I don't know what it is. I went out and I picked her from, Ooh, this will be a good drawer. And then he gets to like right away. So it's not a firms that don't get that, um, drop your answers on the chat and whoever's right. Uh, email us afterwards and we'll send you some swag.Um, here is two days chart of the day. This is going back to like February, or actually this is going back to the start of the year. This is going back to the interests of the start of the year. Now I will give you some hints because otherwise it'd be impossible. I feel like, um, in some respects, this is a technology stock in some respects.Oh man, we can have a winner already. Holy moly. Christian Gallagher. Wait, it was PayPal. This is PayPal. How so are we looking at weekly candles right now? Is this a daily PayPal has gotten beat up over the past month or so it looks like, yes, it has gotten beat up is, is, is, is a nice way of putting it, but yes, Christian Gallagher.Did anyone yesterday? No, Frendo on yesterday. Christian email us shows app benzinga.com. Hey, why is PayPal down so much? Didn't they just announce a Venmo, Amazon integration. So yeah, you would think that tell me you don't own PayPal or maybe you do and you don't know it. Um, I think in my like real portfolio, the one that I don't manage it's in there scourge.It's too easy with showing prices. Well, that's an idea. I take the price off ridiculously hard, but we could do that. Should I buy? I like calls on PayPal. No, it's gotta be coming back up at some point, right? That's one way of putting it. Um, you want to throw out like, uh, you know, you want to buy the, the, the, the, the two 80 strikes expiring and like six months.Really worth looking at. I'm sure it's not very much money. I do think though we have to, um, you know, keep up, like if we start doing obscure biotech stocks, you know, it'd be nearly impossible. So what we'll probably try to stick to, I dunno, S and P 500. Yeah. That's, that's, that's a good plan. Stick to the S and P 500.So we're going to do this everyday. Christian email us shows up and it's going to come. We will hook you up with some schwag before we go to our first guest AB I seem working backstage. Let's do our first crypto update of the day. Sure. Yeah. So yesterday Bitcoin spiked on the CPI data and then gave up all those gains and more.Let's take a look today to see how the, the crypto markets are responding to that yesterday. Uh, we, we have a lot of people in the chat that have been asking kind of how are they supposed to be trading crypto right now? So I know you and I, Spencer are in that boat where we're just like adding Ethereum and not really touching it or selling it.I haven't even added recently. It's been a while for me. I hadn't bought a theorem. I wanted the board. So yesterday, w like I've mentioned, once that CPI data came out, Bitcoin spiked and actually hit brand new, all time highs, um, gave all those gains up is currently trading about $65,000 a coin down 4.8%.Ethereum is also down, albeit not as much Ethereum currently, right around $4,800. So we talked about that $5,000 level being a big level for Ethereum. I think once we see a theory and finally breakthrough that $5,000 level, we can really see it run. Um, but yeah, everything pretty much in the red, like you can see from this heat map Sheba, he knew though in the green up 5%, um, we're actually going to have a big Shiba Inu guest on the show tomorrow.Uh, his name is Ross. He was an early investor and also a kind of co-developer of Sheba. So he's someone that I think I can say confidently knows more about Shiba Inu than 99.9% of people in the world. Um, so if you're interested in Sheba or what's next for the coin tune in tomorrow, he'll be on about one 30, uh, Spencer, any thoughts on this crypto heat map?I I'm trying to get a link right now because we're actually doing a sheep giveaway. I'm trying to get the link for that. I don't have it handy, but we're giving away some free shipping. I hope somebody gets me that link so I can get it to you. Uh, that's my thought, my thought is no. I mean, Bitcoin is an inflation hit crypto isn't inflation, hedge.Um, I don't quite understand the why it's down like this today, but you don't. All you need to do is look at the reaction to Bitcoin at 8:30 AM. Eastern time yesterday, right? Inflation comes out. It's harder than expected. It's it's more than expected. What does Bitcoin do? It goes up. Mike is saying, Hey, be it.It's a good play. Definitely go for PayPal options. Um, so I don't know if he's, you know, facetiously saying that he wants to see me lose some money, but I'm looking at him. I'm looking at the calls. Um, but yeah, Spencer, like you mentioned get some free Bitcoin we'll we'll throw that zing token up real quick.Go to Voyager. You put in a hundred dollars, you get $50 free Bitcoin, if you use the code zing. Uh, so not a bad deal at all. I mean, who doesn't want $50 of free Bitcoin checkout Voyager for that? Use the code zing. Um, all right. Real quick before we get to Ben. Yeah. Yeah. And, and I'm going to post the link to the ship giveaway.Um, when I, once you find that I find it. Yeah, no problem. Somewhere out there, easy Mick, you might be the guy who knows technicals what they're talking about when it comes to technicals, I'm watching a. Dash, which has been up a lot over the past, I don't know, week or so. Is this, is this, this the kind of subtle head and shoulders forming on the, on the one day chart?I think we're looking at five minute candles right here. I see one shoulder here. This could be the head, if this is the, the second shoulder, um, you know, could it start falling down or should I be looking at some dash puts, I need someone who knows technicals better than I do to let me know if this is, uh, you know, I'm not a big patterns guy, so I'm not really know, but we have some people out there that are outsourcing.And I know, I know when I need to listen to someone that knows more than I do. Yeah. Um, Alvin say, and he's looking at Wayfair puts an ADSL. K what's ADSL desk. Autodesk. Yeah, by the way, I just put the link in the chat for the ship giveaway. There it is. There it is. You can't click it on the screen, but it's in the chat.I'm just throwing up there. So y'all know it is there. All right. Y'all so story train. If you guys have watched a show before you've seen Ben on the show, he gave us a E H R at, I don't know, four bucks, three bucks. What does it now? It's like, I like 20 let's check real quick before he comes on. He'll give us an update on AHR.Um, it's at $23. So let's see. I mean, it's, it's up. I want to say like at least 200% since he pitched us to us on the show, he's got a couple more stocks. We're going to talk about, uh, Should we bring them on easy MC RSI? Isn't it. If the RSA is 90, isn't that a sign it could come to? I don't know. You, you know, more about technicals than I do.Let me know. All right. Without further ado, let's go ahead and get BenOh, Ben, what was the, what was the price of AHR when you first came on the calendar? What's up guys? Yeah. When I first came on, the show was around $5, five 40, somewhere that somewhere in the low fives, I believe it was. Yeah. And when we first presented it to our VIP community, when I presented as a trade idea, it was $2 and 74 cents.What, all the way up to 27. So it was a 10 bagger if you captured that. And I happened to pretty much captured that I was done. I'm handing this from 2 74. I didn't sell my first shares until 16. And then, um, I sold a lot more in the, in the 20 to 25, 26 weeks and maybe even gotten a little bit at 27. So, um, yeah, I've got a few updates for you on, on that.And a couple other sucks. Yeah. You got a new background. This is the first time we're seeing this. It looks pretty good. Yeah. A lot more work to do. We got to get that our mikes and cameras and everything, but yeah, this is the first time anyone's seen this background. Cool. And you said too, it looks like we did.It took us far too long, but we eventually got it together. You get a zoom out so Ben can see our beautiful. Oh, wow. That's great, man. Um, all right, Ben, you want to go ahead and get your screen shared and we can go ahead and run through those slides real quick. I know we only got about 10 minutes, so we've got a few I'll work.I'll be fast. All right, there we go. All right. So yeah, first we got that quick disclaimer, we got to always do that. A story is not investment advisor and missing his spirit is in most gimmick where some losses of you who are new to store trading, what is associate is the practice of understanding market pricing.We also call that the story behind the trade through the four pillars, which we say are sentiment catalyst, fundamentals, and technicals. That allows us to take a holistic look at markets and make choices based on all of these factors, not just one of them. So air story, trade idea, update. I officially opened that in my community on July 8th of 2 74, I did close it on November 8th of 25, 79.I still own some shares. Uh, I ended up selling about nine giving 95% of my shares. Um, Monday morning was really the trigger for me and that's because I saw something, the technicals and also the sentiment, which caused me to say, let me, let me lock in these games. And the technicals last Friday was the.Solid green candle on the chart, you can go look it up the first solid green channel and then tire run-up, which, which means it started the day high and then went down lower throughout the day. And throughout this entire run, it was starting low and going higher throughout the day. I took that to be a reversal sign plus the sentiment, I think when reached peak Eby sentiment for now, for this cycle with, uh, Elon Musk selling shares of Tesla with the Caribbean IPO, with excitement, but Eby infrastructure.I'm trying to time that sentiment top. So I took my profits. I am keeping about 5% of my shares because it could go much higher still if they get the right contracts in the future. Got it. Um, so it took some money off the table, trim some of your position and air took those profits, never a bad move. Uh, Ben, what else?I was on your radar today. I wanted to give you an update on side, cause I was on your show. July 26, we presented this at $5 and 70 cents. Uh, this is stuff that's been up 66% since it was initiated in our community. At the time we said, Hey, T-Mobile's come in. End of month in August. It didn't happen then.But it happened last night. Uh, so a few updates. They have earnings last year. Um, so this T-Mobile deal came three months late, but it's finally here. Now, key, this was announced last night on the conference call only. There's no PR yet. So people who are in the know who are listening to the conference call, they have a big edge getting into the stock right now.Um, there probably will be a PR at some point in the future, and there's also tremendous traction with their other customers, 18 T and Verizon. Um, there was an upgrade today to $9 and I'm not even sure that Benzinga caught it, that upgrade by the analyst and $9 by lake street. But we think in our community, it can go much higher.Uh, there's uh, estimates out there in our community saying we can do go up to a dollar 33 DPS by 2024, which would be a $40 price target. So that's the update on SSI. You know, our investigative research worked and we're read about T-Mobile just a few months late. So this company is going to start printing lots of tests going to be a very profitable company.Do, do you have a target? Um, yeah, no, I don't have to stop losses. God forbid men. No, I do stories yet. I never do stop losses. So I've been holding the stock for like two or three years. I increase in decrease my position around catalysts. So, um, I was buying and after hours last night I bought a lot more today.It's now my largest position actually. And uh, I'm not going to put a price target. I see how it goes. I, I assess the fundamental sets of metallics and technicals on an ongoing basis to determine. There you have it. Yep. So I do have a new pig that I'll get to in a second. But before that, just a little quick alert, maybe something for you guys to look into and talk about, because this is a big kind of big cap for us.At $1.5 billion company GoPro. We presented it to our community Sunday night, um, because the fundamentals are super strong. They had earnings last Friday and we have anticipated a technical breakout of the 200 DMA, which just happened this morning. And this is really, it could be a really fun situation, wanted to bring your attention because it has, this has short and gamble, squeeze potential, very high, short position.He has sense of it has been very, very low, but the financials have completely turned around with this company and they're printing tons of cash. Now you see the technicals broke. The options are very liquid, very cheap. And if it gets into the right hands and the Reddit community, et cetera, this could be a crazy profit potential, you know, with shorten game of squeezes.So keep your eye on that. But go. So GoPro's up about 9% today on the strong earnings. Um, so I, I mean, I, I don't know, personally, Ben, if I'm going to go in and try to chase GoPro and it's already up 10%, but I, or 9% today, but I definitely like having it on my radar. Uh, J rice in the chat was also talking about GoPro saying that he thinks it could be a long-term turnaround play.Uh, I don't know. Munis has been one of those stocks that has just been like beaten down over time historically. Um, but you know, at some point I don't think you can ignore the fundamentals or Fridays when I got in added more Monday, uh, I got a little bit messed up on the options than playing the options.So I actually lost some money. Cause I got scared with the whole inflation thing yesterday, but I'm in it now and yeah, the sense of it's sport, that's the only thing people hate this company, but they're printing cash like crazy. The technicals are turning and shorting, given squeeze potential, such that this, yeah, my all hold back a GoPro has always been that.I feel like they have a very limited, uh, customer base, you know, it's like who, who who's going out and buying GoPros. It's people that take part in extreme sports, you know, mountain bikers, snowboarders, skiers, et cetera, outside of that. Um, I don't, I don't know how many, you know, everyday people are GoPro customers.It's absolutely correct. And I'm not, you know, I wouldn't take issue with that, but the amount of earnings they have like 60 million EBITDA this last quarter. And if you compare it with their market cap, I mean, this thing can easily be 17 bucks. Even with that knock against it. Got it. Um, I been, what else is on the radar?I have a presence. It's my first story. Trade ideas. Since air. I presented this to my VIP community last week. Okay. Listen to the presentation. Don't just jump into buying guys. Okay. Because of what happened with their, every stocks, not air, I can guarantee you, this is not going to go a thousand percent in the next three months, like heritage.Okay. So that sock is Gaia, ticker symbol, G a I a. All right. So we're going to look at it and yeah, it's a smaller company on the ground, 200 million market cap or so, but you know, what's the story behind the trade. That's what we're trying to figure out. And again, we look at the sentiment, the fundamentals, catalyst and technical.So let's start with the fundamentals guys, digital video subscription service, like in some ways like, like Netflix, they sell, um, they make original content for yoga, alternative health, holistic healing, nutrition. It's a monthly subscription service. They've been growing steadily over the last many quarters.They're profitable. Uh, fundamentally I think their inflection really happened to a quarter or two ago when they became profitable. And you can see some of the, uh, the trends here in terms of their, um, their revenue and their EPS, although in the right direction. So in our community, we collaborate with people who are really steeped in fundamentals, just charts, courtesy of Mark Holmes.He has a risk reward chart here in terms of what is the value of this stock and. You know, it's worth, it could be worth at least $17 a share. And the stock is very cheap here. So, so that's the fundamentals. You can check it out on your own. Go look at the earnings report and you'll be able to verify everything I'm saying about, uh, the growth and the subscriber growth and money they're making written it now.And it could potentially be, uh, you know, Netflix may buy them out one day. You know, there's, there's a lot of opportunities here. So, um, yeah, catalyst let's go to the next pillar. Uh, in these sorts trading four pillars, they had their earnings just recently, November 1st, it was 20, 20, 20 2% revenue growth, uh, year to date compared to last year Q3 EBITDA of $4 million.Uh, even a margin of 20% was their fifth straight quarter positive earnings in cashflow. Um, and then they had an additional catalyst the next day. So we'll talk about that catalyst in just a second. What happened the day after earnings, but first let's go to sentiment. So the sentiment is kind of poor with the stock because fundamental investors are frustrated at the price action.I know a lot of fundamental investors saying this should be worth 17, 20, 25 bucks. Why is it $10? Why is it moving yet? So I listened to other participants. I say, I talked to people in social media. I talked to people in my community. Why aren't you interested in the stock? And this is what I'm hearing.The total adjustable market may be too small. It may be too niche, their content. We talked about alternative medicine, yoga, meditation, and things like that. So it feels like I'm just not interested. It doesn't seem like a huge part. Other people say, Hey, the content, they have some content that's kind of fringe on their French content.Like some of that alternative medicine, there might be some videos on, you know, some vaccine hesitancy type stuff or who knows, like some things are it's alternative content, right? So some ESG, uh, buyers, uh, may stay away from that environmental social governance. So that's another knock on the sentiment.The other knock is this is just slow and steady growth it's and where's the hockey stick potential on that. So just remember, this is the poor sentiment. This is what happened. Going back to the catalyst the next day after earnings, after we know the fundamentals are great, the next day another catalyst hit the other, the catalyst was there was a PR that Demi Lovato became a brand ambassador for.And there was a press release that a lot of people didn't see a where Demi Lovato says I'm excited to be one of Dias. First celebrity ambassadors, and honor to join a platform. I've been a fan of for some time she has 118 million followers on Instagram. And the market cap is again like 189 million. So this company has been growing slow and steady.And all of a sudden, they hit you with this news of Demi Lovato is a huge mainstream personality, that and company, I want to go back to this. Airpoints the one thing I saw that the thing about Demi Lovato, uh, in, and I, I guess I didn't realize this was the same company, but like they got a lot of weird shit on their platform.And that was the sentiment I was talking to. They're saying, oh, there's stuff is weird. I just don't want to own this company. But you know, I think that, you know, they're growing steadily, they're getting to a place where they can really focus on growth now, and to me, and let me go back to that bad point.You just made that pinpoint. You brought it up for me, right? Yeah. They have weird stuff. It's too niche. The French content. They keep some buyers away. But this is where I think that Demi Lovato news is really significant because they're in a financial position now to really grow the company. And to me, this signals.And in fact, in that PR said, I'm excited to be one of guys. First celebrity ambassador, And I have a feeling this company is going to start growing their content and start getting into more mainstream content. And based on what you're saying, I think they may be looking for more celebrity ambassadors.And it's just a great situation because the downside is so limited. You have a fundamental floor here and now you have optionality upside. If the company starts doing things to get that hockey stick growth potential. And that's why I really add it to my position here. And I'm very excited for the next several months on this stuff.Um, let me just go to the last or technical resulted with her awesome technician Rex. And this is a monthly chart is saying, uh, this can go to the twelves if it breaks out of the yellow.here, which thought is that shorter than I think the current breakout circled right there. It's got a breakout of, I guess, 10 70 area.He thinks it can go to 12 for the month. And here's another view which looks much more bullish. This is a long view of the monthly chart is a sometime in the future. When the 12 to 13 breakout at the blue line, it should proceed to break out the all-time trend at the white line. And he thinks this is a several month play for that to happen, but you can kind of see where this can go.Uh, if that happens. Uh, any questions on that or any of the other stops, man? I didn't see this one coming. I didn't realize this. I read about this company and I was like, man, I didn't even realize they were a public company until you came on here. So, um, I'm all I'm putting two and two together here. Uh, Ben, thank you as always for coming on the show, we appreciate it and uh, and have a good rest of your day.Please follow us on YouTube. Thank you guys. Thanks a lot, Dan. We got to get moving. We got our next guest. She's already here. We're going to talk biotech guys. I know that we, we always get asked. We always get questions like when's Vivian. When's Vivian. When well she's on right now. Not right now. She'll be on in like five seconds when we bring her on.But Vivi Bio-Queen will be joining us every Thursday. At this time, I told you all to save your questions for your bites. The questions for right now, let's bring her on Vivi. How are we doing today? Good. How are you guys? Can you hear me? Well, we hear you. We see you and we have questions. Oh, awesome. And before we do any questions, I think, um, we can do some updates.I did have a request on Twitter to cover it stock. Um, like at my old good lawyer friend, mellow at Twitter, I, this is out for entertainment purposes. So, uh, is only my opinions are for entertainment, purpose, not a financial advice. So I wanted to, uh, first of all, um, talk to you guys, um, just given up a date, we just had the, uh, ER, on KMP.H can you guys put that up over there? Yeah, this is a daily chart. Okay. And P Hit's quiet. So, yeah, so we just had the ER and I want to, so when I, when everybody kept asking me, like, what do you, what are you going to do for 'em? What are you going to do for K MPH? My position was this small because he is a, some of the concerns I had. I spoke to the manager and he interviewed me. And, uh, he said, you know, we're not going to put any reps in New York yet.And it's just going to be certain regions in the United States. And for me, it showed a little bit of a weakness because for me, if you launching a drug, you should have put reps all over the map. But I think they're just trying to be cautious. So they report around like, I think 2 million in revenue, but here's what I'm bullish.Now. They just launched the rest of the Salesforce. And this company here, you know, their burn rate is really, really small because Korean is doing all the selling. So the burn rates is like a million a quarter and they have a, still have 135 million. And he is what I'm bullish of. Um, there's a company that sells a scripts and there's a guy that, uh, his friend works for this company and feeds him all the script.So for you guys to have an idea, right, the, the feedback has been amazing. So July, they had a nine scripts for the monthly and then August, they had 173 scripts, um, September 416, October 886, still low because there were not out throughout the nation. But I think the feedback has been tremendous from psychiatrist, from the drug and the differentiator.And I feel like as they deploy, uh, the other sales reps, we going to just ramp up the sales. So I feel like at this moment, I wanted to add a little bit more to my position because I, I see the future being very bright here, KMBH. And I think that, um, we gotnot yet. Not yet. I, I should have now I have an, I am waiting for some of my swings to flourish, so I haven't been able to, to add, but I wanted to for sure. Okay. And then I want it to put you guys out. Somebody asking me to, uh, to, uh, cover a, uh, a N N S. Hmm. Okay. Now I want I'm familiar with, but it is biotech.So it's a biotech it's under the radar. So I wanted to explain to you guys some of the reasons how I invest in biotech, and I told you guys, if there's no commercial products, there's, there's got the most important thing you can look at is cash, right? Because if you don't have a cash, no product, are they going to burn too much?And they also gonna have a, to do offerings. And if the stock is low, they do reverse the split. So the first thing I do is to look what was the cash burn and how much cash they have left in a would the future and what the catalysts are going to be. So this company here, the first thing that got me to, to look at it was they have a $271 million in cash.So they're really the city really strong. So I thought that was a really, really, uh, um, uh, valid, uh, information, very important. Then I look at a financial institution on. EVestment, which is a goblin, was the director of FDA is a partner on their firm. So they own 2.5 million shares. So I thought that was another very important information because goblet is well connected to FDA.Not that you know, it nobody's going to be bought out, but when you have investors that work with FDA, they know what it takes to, to be compliant, to get a drug approved, right. Because it's just so much behind to get a drug approved. So manufacturing, you know, how the studies are designed. So I like the fact that there's Nia investment behind.And then I also know VOD is, oh, 2.1 million. So Novartis has some interested and, and the pipeline, it looks really, really amazing is all CNS, um, uh, and mass. Um, they're going to have, uh, Gilliam Barre syndrome, which is a very rare disease. So I really like this company. I really do. I, I'm not, uh, obviously I can't be in every single stock.Uh, but I, I, I, I think this is a really good a long-term, uh, stock to hold for sure. So that would be one. And then if you can, um, bring back, uh, pro GPRO G we have a lot of fans PRG. It's like almost like a min stock, but also a really good stock to hold long and, um, really. Yes. Yes. So, so what, what do you see that the market doesn't see, um, what I see that the market doesn't see.Um, I will tell you why this company is going to be huge. They have a two types of, of delivery system. They have a, um, on, I'll tell you guys, they have a two to two technologies and I wanted to bring to you guys, let me see. I can share a screen. Okay. But I have it here right in front of me. So they have two things.They have the OBDs okay. Which is oral Biotherapeutics delivery system. So what it does is, is able to take big formulations and put in a form of a pill. So for example, Humira is one of the biggest blockbuster drugs in the world. If they found a $10 billion. So you imagine if Abby, I think Abby is a Humira honor.If, imagine if Humira is loses patterns and five years, right. And all of a sudden, because doctors love the efficacy of this drug, and that's why it's so well prescribed. Right? But it's an injection. Imagine for this company sell their technology. And all of a sudden you can have a drug, like a Humira being, um, given orally, all of a sudden you create a whole new patent for that drug.Do you follow me? Because a different formulation. So all of a sudden you gaining another 15, 20 years. I have a patent on that drug. Now imagine how many pharmaceutical companies would have be jumping all over because they like, geez, I have this, this drug that's high formulation. And now I have a, I would love this drug to be an oral form because patients do prefer to be an oral form.So I see, um, they announced that they have three partnerships with the big pharma, but they have announced who, so everyone is kind of on a suspense, like who are going to be the big pharma. So they have, uh, right now with the Pfizer there, just to have an idea, they, the not only the delivery, the delivery system does this to the big formulation, but also one of the drugs of four in any boat to the second one, the oral bio biotherapeutic delivery system.The OBDs, what it does is it's designed it to, to, um, to take it a pill and the pill, the way this delivers it, doesn't go all over your bloodstream. So it's it's for the GI tract. So is GI specific drugs and there's one. For for, for, uh, uh, Pfizer they're there. The preclinical, what they found was not only that, that would their delivery system, that drug was 25 times more potent than the Pfizer drug, but had a no toxicity because it doesn't go to the bloodstream.Like the other drugs would go. So you have a less toxicity, less, less side effects. So imagine what they can do if they already doing this with Pfizer drug, they're studying the Humira. Imagine like for me, this drug should have just literally like get royalties for every farmer, choose the technology instead of it being bought out.Right? So I believe this, the future of this company is super, super bright. Uh, you know, it's heavily shorted. So I think that a lot of people are here for the, the, the, the gum is squeezed because if you look at the amount of, of, uh, of, uh, options, that the options chain is crazy, uh, for this, for this company.But I, I will, like, I have a big position because I wanted to, you know, to trade around my core, but it's some, it's a company that I wanted to keep it. And, um, and a long term, uh, option, because I feel this company is going to be huge. So they just appointed also geo hall, believe it or not do, how do you, how, um, she's in a board of directors and this woman, it's like a powerhouse in biotech, a friend of my work.As so maximum, so messenger gas sold. So she comes in with a lot of experience in pharma and a lot experience in acquisition. So, uh, the team is fabulous. They are four miles away from my house. I should have just bring them a bottle of champagne when we hit $10. But I believe in this company, this company has a bright future and that, um, right now there's a lot of people on it, you know, waiting for that short squeeze.But, uh, it's been keeping really it's being holding like it dipped to, to like 2, 3 0 3 today and it went right back up. So it's been keeping, you know, I think the short sellers were expecting after der cause you know, there's, you know, a yard for a state, uh, initial stages of biotech doesn't produce revenues.Right? So it, it dipped to fund 360 2 all the way to three, but it's been holding for weeks at that average. So people are not selling people believe in this company for sure. Uh, can I ask you, what do you, what do you get, do you have any favorites in the, in the gene therapy space? I do. I, um, I, uh, I, I'm a loan holder for ADP and they have the, uh, it's one of the car T therapies, but it's not the car T is the RTC, uh, ADP.And, uh, the reason I like this company is, uh, not only they have a partnership with Genentech, uh, the Genentech partnership is up to three. And, uh, they already have enough funny from Genentech cause they got, they gave them a prompt payment payment. They have funded into 2024. So I feel like this is a very safe play in regards to not having offerings and that they are sitting with 285 million in the bank and they do have, uh, some, um, some, uh, catalyst coming.And, uh, I, I believe this company will be a multibagger on day, you know? Uh, so it's one of those that you set and forget it, but I like the position of cash because it gives me the comfort that they're not going to be throwing in offerings after a big catalyst. You know, they, they have they're in a really strong position.And when you look at, uh, um, institutional ownership matrix, all 15 million shares of this company, baker brothers owned 18 million, the institutional ownership. It's so strong in this company. And obviously Jen at that has a huge, huge portion of the company and has their eyes on the company. So, uh, this, this is a big one for me.I got to ask you about, about BCR X here. That's the rule. Every week we got to talk about BCR ex of course, it's this year access to my unicorn. You guys, for sure. So, um, it's, it's funny. I held this space as on Twitter yesterday, and I was talking to a pharm D you know, I do respect, they have a lot more knowledge than me, you know, uh, in terms of a clinical.And he validates my position on the CRX and GRTs, which is great stone. And he says to me, you know, be CRX is, is a rare diseases monster in the making. So they, um, they just released the earnings. They put 38 million for the quarter, and people, BU people were really upset that it wasn't 7 million like this huge numbers, but for the mentally long-term, it's still there, right.Because the science hasn't changed. So I see this as an amazing opportunity, uh, if you're not in the CRX, but, uh, just, you guys have an idea. Uh, the biggest drug for, um, for Alex yawn is, uh, Alto Morris. And they are not even that good because it's not only an infusions for PNH, but patients still need transfusion, uh, taking this infusion every eight weeks.Uh, BCRA X has the competitor, which is going to be an oral oral, uh, competitor factor D and not only patients that have been on this study up to now, not only they jumped from phase one to phase three, because they did so. Patients to this date. I think there's 40 weeks, 30 weeks of, could it be this fusion to this date?So imagine having a drug that is, it's already a rare disease for PNH and patients only at the choice on the available is in Jackie, no infusions. And you still have to go through the transfusions. Imagine having an oral pill that you don't have to have a transfusion at all. So just make them do the math and Alex, the on 70% of its revenue, 70 was on PNH for this drug and they got bought out for $39 billion that would have put the CRX at a $230 a share.And B CRX has a better pipeline with a more potential and it's going to be all oral. So you guys do the math, if you don't think this is a monster in the making. Alright, Vivi the bio queen, she joins his every single Thursday at biotech. Underscore SD is for Twitter handle it's up on the screen. And uh, and then please.Yeah, please, if you, I will post my DD there because this is a very short, so you guys searched the bioclean on Twitter and you can find me all right. Thanks a lot. Viva, talk to you again next week, next week. All right. Uh, Hey, let's stick with biotech for a second here because our next guest is the CEO of a gene editor.Company, hence why I asked to VV about that one to get her thoughts. So, uh, if we can, let's go ahead and, uh, and, and, uh, bring her on guys. Andy Ford. She's the president CEO of Mira GTX. His company is a lot going on right now. They're at a very critical point. So let's get Zandy onum, Ford,by the way. Yes. Thank you. Thank you. Where we're actually, it's on our to-do list to get new music, but, um, thank you for, for, for the compliment. Uh, so as I said, it's a pretty critical time for, for mirror DGX. Uh, you guys just presented at, uh, uh, the virtual, uh, oh gosh, uh, the European society of gene and cell therapy Congress, right?Uh, yes, we did add three abstracts. Yes. Right. And then there's a, we're due for another, a little bit surprised when I found out you're on the calendar. Cause I thought you guys, you have another, uh, presentation coming up in a few weeks. I, I, I think I believe right. We do. So we have, um, quite a number of presentations in the second half of this year, uh, which included, uh, some presentations at the meeting.You just mentioned on our programs and our switch that allows you to switch gene therapies on and off with a pale. Um, related to what video was just talking about, actually, that's what I do want to talk about. I'm sorry about, and then, uh, at the beginning of December, we, uh, having a clinical update on our xerostomia program for patients who've been cured of had a neck cancer, but don't make saliva.So we'll be completing that study this year and we'll be updating on the clinical progress so far at the beginning of December. And then a couple of weeks later in mid December, we're having a science day to discuss in some more detail, uh, Ribas switch technology and our promoter platforms, which allow us to really optimize gene therapy.And for the first time switched gene therapies on and off with an oral drug and not just switched them on and off, but quite precisely dose the amount of gene therapy at a particular time with a dose of an oral pill. So let's talk about the switching via via pill. Yes, exactly how that. So obviously gene therapies are a virus which contain a gene and there's a coding sequence of the gene, which will make your protein, whether it's Epogen for example, or whatever, uh, gene therapy, it might be RPG or for the eye.And that gene is activated by a promoter, a regulatory sequence at the beginning of the gene. So that's the normal gene therapy promoter and a gene, the promoter switches the gene on, and it remains on for the rest of that patient's life, all that sells life. So you have persistently expressed gene therapy, but what we've been able to do for the first time is we do everything.I've just told you with the promoter that regulates the gene therapy and switches it on. But on top of that, we put into the gene sequence, a small sequence of DNA, which instructs the entire RNA produced from that gene to degrade. However, if we give a small molecule, but via pill, and we've got many small molecules, because we've developed this as a platform, it stops that degradation.It cuts the entire degrading sequence out of the gene. Produced RNA and you'd get the gene switched on as if it was never there. So for the first time we can deliver gene therapies, which are not on, so they're not producing weird proteins or bits of proteins. And we give a pill and bomb that I'll call it.The degrading signal is cut out of the RNA and you get a perfectly normal protein product.I guess I have so many questions. I don't even know where to, I like that all sounds incredibly complicated. Um, I guess, uh, how can you make sure that it works? So it's, we've when we set up the company, this was one of the technologies that we, um, we wanted to build and these switches made of RNA shape.There are thousands of them and bacteria. And for, for decades, people have tried to take bacterial switches and make them work in human cells. And rather than doing that, which hasn't worked very well. We built, we use the theory of Reiber switches and we built based by base our own switch. So we built it in mammalian cells.We then tested many switches and we have a platform of switches we can control. We were able to make these really simple switches, which switched on and off to high dynamic range. So 5,000 fold above the off level when they're switched on. And as a consequence of that, we were then able to change the drug that we activated with.So now we have multiple genes that we've put our switches in sitting in our freezers. So, uh, various antibody, PCSK nine antibody. You'll be aware of, uh, PD, one antibody, the, the very large drugs we can regulate. And then other drugs like GLP one, obviously a diabetes and obesity drug, which we can regulate.So we've got those genes and we can now put them into vivo in mice and NH PS, and we give those animals small molecules and we've already shown. Based specifically on the dose of the small molecule, we see our drug switched on to exactly the right level in each animal, depending on the dose of the small molecule you give.So we have built this over the last five years and we have moved from cells to mice, to non-human primates. And we're currently in a position to start doing I N I N D enabling studies for both the small molecule, all drugs and the genes that they regulate. Uh, and then as far as use cases, I know you're working on, um, you know, you're working on applying this, um, to, uh, I disorders, right.Uh, but is that the only use case right now? Tell us about the other one. No. So, um, we developed this technology of controlling gene therapy with a pill in order to much more broadly open up the space that gene therapy could be used in. So. We do have a lot of expertise in the eye and a partnership with Johnson and Johnson for our rare eye disease programs, but in diseases like wet AMD or dry AMD or uveitis, those large diseases.These are targets for regulation with our cassette and small molecules. In the case of our wet AMD program, we inhibit VEGF like other companies do. But what we're able to do potentially is when we put that gene that blockades by Jeff into the eye, we can formulate one of our small molecules. That's otherwise oral into eyedrops.So what we're working on now is turning our small molecules into eyedrops. So we can put a wet AMD drug or uveitis drug into the eye as a gene and switch it on each day with an eyedrop. So the eye is an excellent place to be able to regulate gene therapy with a small molecule, another place, which is really important is in the brain because it's very difficult to get antibodies or biologics across the blood-brain barrier.But what we're able to do potentially is we have regulated antibodies and we can put the. By an injection into the brain, just a one-time injection within the blood brain barrier. And then all you need is a pill which crosses the blood brain barrier. So it allows us to deliver drugs that really hard to deliver by other routes.And there are many, many more applications. It, it hugely expands what you can use gene therapy for, because for the first time you can control how much you gave. And at what time, uh, it seems like broadly speaking Zandy, um, gene therapy, like what, like as an investment, it was like super sexy a couple of years ago.Right. And then it sort of, it was super hot and then came down a little bit and was like, oh, wait a minute. This is still really days. Where, where are we now? Are we like back to, is gene therapy being like the hot, the hottest topic in biotech? Or, or are we still sort of, is it like the off cycle? I dunno how else to phrase it?W well, I think there are, there are many different gene therapy companies and there is cell therapy companies. There are very, very large number of, of, uh, therapies in the genetic medicine space. And, um, and there are some companies that just have a product or a platform or a particular organ that they focus on and that.Is a somewhat higher risk to those companies that depend on data around a particular study, right? What is quite different about mirror is that we established the company to really innovate in gene therapy and shows indications in the clinic that had good proof of concept and highly likely to work and to support a future pipeline.We built everything you need to be a gene therapy company in-house so we have multiple promoter platforms, multiple capsid discovery efforts. We have our own internal manufacturing, which is probably the broadest engine therapy today in that we manufacture our own GMP plasmid. We have two, uh, viral vector manufacturing facilities, which are flexible and scalable to commercial scale.And we do our own QC and analytics as well as potency assays. So we have a very, very broad, I suppose, toolkit that's required for anything. That you need to do in gene therapy and went out, positioned with this regulation ability with a deep pipeline of regulated genes that we can then take through to the clinic with our vector ecology and our own GMP manufacturing,not of the regulatory by putting all that in house. I was just gonna ask, as, as we get more developed in this space, like Spencer said, it seems like a couple of years ago, you know, that the gene editing space was huge for investors. Uh, what advice would you give investors that are looking at different, uh, you know, genomics companies to, to be able to discern which ones are going to have an advantage in the, in the field once the industry does become more hot among investors?Again, I do think that right now, manufacturing is not just a bottleneck with respect to capacity, but, um, Dealing with regulatory agencies globally and an expertise in manufacturing process. And, uh, and the assets required to show the release and stability of your products is very, very important. And to be able to either have that, to have as much of that as possible in house dearest clinical programs that you'll see, particularly if you have those sorts of capabilities at the time of D you really don't want to see companies that are starting manufacturing their product in one way.And then at phase two, switched to another way and then have to scale it later. Ideally, you would look for companies that have capabilities that allow them not to necessarily rely on CRS for plasmid manufacturing or in DQC. And we learned that over the last five years, it's one of the reasons we've bought, uh, so many of these capabilities in house, but I do think that's very important.Um, in addition to obviously, you know, do the targets work or is this, is this an appropriate, um, disease for gene therapy, the nuts and bolts of being able to produce and show the agencies that you've produced the right thing, a really important. Zanni Forbes is the presidency of Mira GTX. As I mentioned, there's a lot going on.You guys also got some positive in Canberrans over the weekend and, uh, uh, a lot of presentations after being in stealth mode for quite some time. So, uh, looking forward to seeing how things develop here and, uh, and, and, and good luck going forward. Thanks a lot for coming on today. Thank you so much. All right.Hey, w we got to keep the train running on time here. We've got so many guests today, back to back to back to back let's pivot. If we can, maybe we just spent the last half hour or so talking biotech, uh, let's pivot to like supply chain, specifically, uh, supply chain of textiles, right fashion. And what exactly is going on there?What to find out? We're going to bring on our next guest here in just a second and running Samuel. He is the CEO of a cornea technology, and, uh, let's bring coordinates and a Ronan. W that's been running on this show. Now, if we can guys, I guess I'm Spencer, I guess I'm doing that. All right. I got you right.There you go. Good morning for us this afternoon for you it's later on in the evening. So I appreciate you, uh, coming on, uh, the, the, uh, the show here today. So, uh, let's talk about textile supply chains, right? Uh, what exactly is going on there right now are things as bad there as they are in other areas of the.Well, um, yeah, it's bad. And it has to change the supply chain is broken, but even more than that textile industry and fashion industry in particular is the second most polluted industry in the world. Um, from different reasons. One of the reason is that 30% of whatever put use on textile is actually never been sought.Uh, and this create a huge amount of waste, both of materials and water, and we have to save the world. Um, uh, so we have to change the industry. Now, the reason for that is some of it is because the supply chain of today doesn't meet or doesn't fit the need of the consumer of today. The supply chain of the textile industry is like centuries ago, you produce in large quantities in forest, in China, in Magilla dish, you trying to forecast what the consumer, what the people would like to buy a year in advance, sometimes 18 months in advance, which is impossible.It's crazy to think that you can predict what the consumer today would like to wear in a year and a half from now. So we have to change it. The world move to digital in many, many industries. And in this industry is still fully. Yeah, I'm glad you brought up the, uh, you know, the environmental impact of the textile industry, because that's something that's gained a lot of attention over the past year or so.I mean, you have a quote unquote fast fashion companies, such as sheen and people have kind of started attacking the, the idea that, oh, buying, you know, a cheap t-shirt for $15 or some pants for $15 that you see an ad for an Instagram, uh, causes a lot of environmental distress. So what do you think needs to be done in the industry to address that?So they, this would need to change in order to try to predict what the consumer would like to buy and put, use Lauder moms of products, which will never been sold is to produce, to demand, to produce after the consumer.But that's not efficient. I mean, it you're saying it is, but that's not a necessarily inefficient use of capital though, right? No, no. It's, it's actually a very, very efficient, um, hold on, explain to me, explain to me, yeah, let's begin with, first of all, what we see that production is really moving on shore.Why it's moving on shore, not only because the, the, the supply chain is broken because you have to be closer to the consumer. You have to react fast for the consumer trends. Now, the world of fashion and textile move is moving online today. 30% of all purchases being done online. So e-commerce the focus by 2025, that it will be more than 60%.Now, the online the e-commerce of today is still trying to sell you what they have in the inventory or what they have in the shops, in the stores. Uh, and if you going to order products, sometimes it does not exist at all. Um, and uh, sometimes, um, for the brands is really, really difficult to. Okay. Can you hear me okay?Yeah, we, we, you we're fine. We just got disconnected, but we're back. Okay. So, so I missed everything you just said. Okay. Okay. So let me try to explain again. So the world is moving digital. What does it mean? The consumer today's buying? So e-commerce online. 30% of all sales is being done online and the focus by 2025, that it will be 60%, but the online is today's actually a mirror of the store.Doesn't allow you to choose your product. They're trying to sell you what they have in inventory, which doesn't fit what this consumer would like, what we believe needs to be done, that the online should be filterable. You shouldn't have any real physical products. You can have endless amount of product virtually and connect the virtual wall to the physical world.And this is exactly what committee's doing is enabling on demand, production. You order what you want only. Then you produce it. You produce it close to the consumer. Onshore and delivering, you know, the same day on the next day to the consumer, the product, I feel like this is I'm in now. It sounds great. I think that, but that's like, that's more difficult, right?Well, I give it a few examples. Well, one example, great example. Thinking about the books book markets, um, back at 25 years ago was fully analog. You went to a bookshop, you tried to buy a book. You only have them, the shelf, the books that we're selling in millions of copies, Amazon disrupt this market. They created a digital world.You could go to Amazon buy any type of book, even from 200 years ago. But what they create is actually much more, the impact was much more than that because now everybody can become a writer. You can write a book about your family, about cooking, about anything you like, you publish it. Virtually doesn't cost you anything.Only when someone is ordering, then you print it and send it to the consumer. So the same thing is happening now in the fashion world, you don't need to have it physically. You actually unleashing creativity because you can have endless creativity and each one of the consumer can choose whatever they want in any Colleen, any design.And once you choose it only, then you produce. So this is efficient and there is no way. And you produce it using coordinate technology, which is a fully sustainable green technology. That was my next question was just if you to clarify that, so I come up here like Amazon, for example, uh, could have used your technology, right.Or, or any retailer, right? Could just buy your technology and, and use that along their supply chain to make it more and more green, more efficient. Right? Actually, Amazon is our biggest customers. Okay. Amazon is our biggest customer, but we have many, many more customer. We are worth more than 1000, 300 customers that using our technology all over the world.Some of them very big companies like Amazon, like Adidas, like fanatics, but using our technology. And you can go online and order products and customize the product and order your t-shirt here. You can see with coordinate on top of that or on any color, any size, any shape. And this is the new world. Look what the world is moving into.What is moving into metaverse. So metaverse is everything is virtual. You will have. Your image in the metaverse. Yeah. You will be able to dress it as you wish with any, any type of, of, of goods. Uh, and only when you feel that you lack it, then you order it and then it would connect it to the physical world, which will be big produce next to you.If you are in New York, it will produce in New York. If you are in Beijing, will be produced in Virgin and shipped to you the same day. So the impact on the environment in terms of sustainability is huge and their efficiencies and believable, and the creativity is unleashing the creativity for the designers and for the brands.W why is no one else doing this? Or are they well, uh, there are some, uh, companies, our customers that using our technologies like Amazon are doing it. If you go to Amazon and you're doing what you're doing, right. That's what I meant because, well, we are kind of unique festival in terms of the physical world.We out technology, what we have developed is systems Inc services that is all sustainable, which are digital systems that can produce one off. If you want it to produce a t-shirt or any, any government or any fabric in the, in, in the past using analog technology, you had to print where to produce hundreds of meters in order that it will be economical and.The sustainability impact is huge. Um, there's a lot of pollution and consumption of water for every meter without technology, because it's digital, you are not limited. You can print one t-shirt, you can print one meter, one fit, there's no limitation and every feed can be different design. So this is the advantage of digital is unleashing the limitations that you had before, and we are not using water.So there's no, there's no water consumption. It's pigment ink. So it's fully green. So no impact on the environment. So like who couldn't use corny Amazon obviously, but they're the largest retailer in the world could, could, could I use it on my online Shopify store that make, that sells? I dunno, 10 shirts a year.Exactly the point it's off form. The biggest retailers, biggest e-commerce biggest brands like Adidas, Nike. They of course can use it to anyone, any consumer that would like to open a shop in Shopify. Now, what is the problem with Shopify? If you are now at this time? And you see somewhere in India and you would like to, to sell your product.You open the shop in Shopify in five minutes, you put your design, what is the problem? Once you get the order, what are you going to do with it? How are you going to produce it? Are you going to ship it out? We can compete against other marketplaces. What call Nita Naples is to connect all those and marketplaces all those designers in to a network of fulfiller that can fulfill for them.So you need to take care of only on the design, open a shop, and then connected to Coney ticks. And kinetics is a platform that connect them to a network or fulfiller that using our technology and can produce it anywhere around the world. And it sounds good. The market clearly likes it. Cause if you, if you look at your stock, it's had a pretty tremendous run actually, even, even last year, uh, seemed to, uh, COVID, didn't seem to hold it down too long.So, uh, the market agrees with you. Uh, so I, I guess keep doing what you're doing. Uh, running Samuel was the CEO of, uh, coordinate, uh, digital. Uh, we will have to get you back on the show. Uh, hopefully, uh, now maybe next year when, when the supply chain starts to work itself out a little bit, but I, I I'm, I'm very curious about this space because, uh, you're, you're one of the best performing stocks, uh, I think out there probably right now.So, uh, Ronan, thank you so much for coming on the show today. Thank you very much. Pleasure being here. All right. Uh, it is, uh, 1259. We've got our next guest coming on in couple minutes. Whenever minute when it, whenever they join, to be honest, cause they're not even here yet, but that's okay. Uh, Scott Mathis is the CEO and chairman of Gacha holdings, ticker V I N L a.And then we have, I'm very excited for our one to 30 guests, but we're not a Capels from Benzinga and, uh, really Benzinga is, is a side it's his side gig. His main gig is, uh, is doing really complex. Trading stuff, strategies. So, uh, I'm, I'm very, I'm very much looking forward to that, uh, in a half hour. Uh, if we can think of who executive though, and I have not grabbed, voted for likes yet this hour as we enter our two of our show keyword yet, uh, if you could be so kind and hit that thumbs up button on your screen, I'm not sure where we're at on the light counter right now.Let's look, we're at the de come on computer 74, 75. We can do better than that. We do over a hundred easy, easy. The goal for the goal for the day is 200, but we can get you a hundred right now. I suspect. Yeah. So before we get to Scott Mathis with a wild show holdings, um, the, uh, the previous guest, I liked that idea of cause basically what he's saying is that companies now are producing clothes for a year down the line, right?But they don't know what's going to be hot on Instagram and Tik TOK and what the trends are going to be efficient. It's not efficient. So what, what he's saying they're doing is waiting and basically it's print on demand, but on a huge scale, like what Shelly was talking about in the chat with the economies of scale, they're able to produce, uh, the goods for cheaper when they're doing it on a large scale.If everyone, if they're, if their technology is able to kind of shift that whole industry, it would have a tremendous impact on, uh, the environmental right now, the negative environmental impact that the textile industry has. Another fun fact. Spencer, did you know this, that a lot of luxury brands, um, such as, you know, Gucci, Louis Vuitton, do you know what they do with their extra extra goods?No, I don't want to say something that's politically incorrect, but I know I have no idea. What could, what would the, I don't know. They, they, they, they give it the, give it to animals. I don&

Controversy alert.  In this episode, the dads have some upheaval as they break down "How Fathers Can Avoid Pitfalls of Shifting Parenting Roles According to a Therapist" by John Duffy. Which side of the dad takes will you see?  Then in parenting tweets of the week, MK continues his disdain for Halloween Costumes while Mark and CRX double down their love for the holiday. Then the dads try their hand at a Halloween candy quiz brought to us by PBS and a few thought-provoking questions during "Would You Rather." Finally, we'll find out which dad dressed up as the Gilligan and Skipper with his wife and wrap up with things ever so gently in the things that make us smile close.

As we arrive to the summer season in fashionably late style, the full seasonal crew are here to lay out the diamonds in the rough of a very meh season that seems to be as such before fall arrives for another overwhelming feast of quality content and programming. But despite being a very average season, there was still enough to talk about to make this a two-part episode. It always seems to happen in such a way. In this second part, the discussion of Funimation's summer pickups continue before going to the strange pile that Crunchyroll has amassed - some good, some bad, a few headscratchers, a BAD case of polyamorous romcom-itis, and even the true best show of the season that everyone should watch because Jahy is all and all is Jahy. May her reign of dominance and minimum-wage survival be an inspiration to us all. And yes, we will be talking Crunchyroll next time. Along with Evangelion and Discotek and Fena: Pirate Princess and CRX and everything that happened this week because EVERYTHING happened this week. start-31:01 - Funimation (second half) (The Duke of Death and His Maid, Life Lessons with Uramichi Oniisan, Scarlet Nexus) 31:01-end - Crunchyroll (Dragon Maid, Girlfriend Girlfriend, Jahy, The aquatope on white sand) additional audio from: Jellystone! The Stranger By the Shore Seinfeld “Forget Me Not” - ENHYPEN “Red Criminal” - THE ORAL CIGARETTES "Ai no Supreme" - Fhana "Fuzaketenaize" - Necry Talkie "Tayutae, Nana-iro" - ARCANA PROJECT "Gamble" - syudou "Fightin★Pose" - Yui Ogura Apple Podcasts – https://itunes.apple.com/us/podcast/podcastona/id1348141210?mt=2 Google Play – https://podcasts.google.com/feed/aHR0cDovL3d3dy5wb2RjYXN0b25hLnN1cnJlYWxyZXNvbHV0aW9uLmNvbS9mZWVkL3BvZGNhc3Q Spotify – https://open.spotify.com/show/2JZLO3LfoeHepomejTw4TP iHeartRadio – https://www.iheart.com/podcast/256-podcastona-43099114/ TuneIn – https://tunein.com/podcasts/Podcasts/PodcastONA-p1249922/ Stitcher – https://www.stitcher.com/podcast/podcastona/ Where to find us: Alex – @AuraOfAzure Andy – @MangaMan9000, youtube.com/DubTalk Jet – @Divinenega, animationinfinity.com Duelist – @HeartofSword75, youtube.com/DuelistG Megan – @queenira2, youtube.com/DubTalk Sketch – @Sketch1984, soundcloud.com/toonamifaithfulpodcast As always, check out surrealresolution.com for more content, and follow @SurrealReso for more updates on the show, our continued news posts, reviews, and our fellow podcasts.

What's Good? We watched as much CRX as we could muster and realized it would be more beneficial to talk about Shirobako. What a fantastic movie and continuation of the series.   News Funimation and Crunchyroll are officially both owned by Sony. Cartoon Network Studios and Warner Bros Animation are beginning to produce anime. JoJo's Bizarre Adventure Part 6: Stone Ocean will release on Netflix December 2021. Astro Boy anime producter Fred Ladd passed away at the age of 94.   Shirobako the Movie Studio: P.A. Works (Aquatope on White Sand, Maquia: When the Promised Flower Blooms.   Our intro artist! Soundcloud: https://soundcloud.com/tomnasr Instagram: @tom_nasr Youtube: https://www.youtube.com/user/SuperArmhair                Contact Us: Facebook: https://www.facebook.com/instantramenpodcast/ Twitter: https://twitter.com/InstantRamenPod Instagram: http://instagram.com/instantramenpodcast E-mail: instantramenpodcast@gmail.com Twitch: twitch.tv/krispother What we've watched: https://docs.google.com/spreadsheets/d/1dOnuaP2W--abNIJPF1nwlLoNnD-SHUkuTP_AuLm9ass/edit?usp=sharing  

Advances in research have led to increased interest in the properties and potential of cannabis to treat many illnesses that have alluded modern medicine. Now, practitioners and consumers turn their attention to the role that it may play in the treatment of COVID-19, the disease caused by the coronavirus SARS-CoV-2. Special guests: Jason Nelson | Senior Vice President, Horticulture Marion McNabb, DrPH, MPH Founder and President Cannabis Center of Excellence, INC The focus has been on the immune modulation and vascular effects of cannabis.1,2 As with any pharmacological treatment, the effects will depend on patient specifics and the stage of disease. To grasp the current state of research, CRx evaluates the weight of evidence and speaks with experts in the field of medicinal cannabis. When working with medicinal cannabis in the age of COVID-19, it may help to think in wo separate categories: COVID-19 naïve (cannabis use in a population that is not and has no record of having been infected by COVID-19) and acute COVID-19. Can Using Cannabis Make People More Susceptible to COVID-19 Infection? David Bearman, MD, executive vice president of the American Academy of Cannabinoid Medicine and a certified cannabinoid medicine specialist, notes that it's important to distinguish between adult and medicinal cannabis use. Concerning adult use, Bearman would err on the side of caution and recommends people “take an herbal vacation until they've been successfully vaccinated.” If a person is using cannabis to relieve symptoms of a serious illness, such as cancer or epilepsy, Bearman believes it may be beneficial for some patients to continue treatment but makes it clear that “risk assessment for cannabis during the COVID-19 pandemic needs to be made in conjunction with the health care provider on a case-by-case basis.” The intent is to ensure that potential benefits outweigh the risks. Bearman also emphasizes that any inhalation—whether via smoking or vaporizing—increases a person's risk of COVID-19 because the respiratory route of cannabis increases both sputum and bronchial irritation, making a person more susceptible to infection. Essentially, if cannabis is being used medicinally, clinicians should discuss the immune modulation effects and route of administration with patients. Reference Links: COVID study data will be released in August 2021 when the study is completed Cannabis and COVID Research Event held by COE in Dec 2020 with 6 COVID and Cannabis Researchers Link to sign up If companies are interested in partnering on the Healthcare provider medical cannabis study this year with COE and Medicinal Genomics https://www.cannacenterofexcellence.org/CCOE on Facebook, Instagram, Twitter See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Nothing like climbing into a little history, especially when it's the great Japanese and USDM stuff from the late '80s and '90s. You name it - CRX, EF, EG and EK, S-13 and S-14, good seats and bad grounds, cotton and foam intakes, STILLEN, RNC, Jackson, HKS, Road & Track, Flyin' Miata, GTR, NSX, VQ, 350 and 370Z, fart pipes and blow-offs, 1J and 2JZ, straight fours and sixes, FJ40s and 80s, and whatever else we come up with. Meanwhile, the Garage Hour breaks in some new meat with the introduction of Mr. Intolerant, plus sips of What It Is kolsch and Dark Cherry Seltzer from Trinity Brewing.

This is our recording of the Crunchyroll Expo 2017 masquerade and awards presentation in Santa Clara, California. Our complete coverage of Crunchyroll Expo 2017 can be seen on AnimeCons TV.

This is our recording of the Crunchyroll Expo 2017 masquerade and awards presentation in Santa Clara, California. Our complete coverage of Crunchyroll Expo 2017 can be seen on AnimeCons TV.